The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo
Abstract
BACKGROUND: Earlier work from our laboratory highlighted the therapeutic potential of curcumin (turmeric), used as a dietary ingredient and as a natural anti‐inflammatory agent in India and other Southeast Asian countries. This agent was shown to decrease the proliferative potential and induce the apoptosis potential of both androgen‐dependent and androgen‐independent prostate cancer cells in vitro, largely by modulating the apoptosis suppressor proteins and by interfering with the growth factor receptor signaling pathways as exemplified by the EGF‐receptor. To extend these observations made in vitro and to study the efficacy of this potential anti‐cancer agent in vivo, the growth of LNCaP cells as heterotopically implanted tumors in nude mice was followed. METHODS: The androgen‐dependent LNCaP prostate cancer cells were grown, mixed with Matrigel and injected subcutaneously into nude mice. Experimental group received a synthetic diet containing 2% curcumin for up to 6 weeks. At the end point, sections taken from the excised tumors were evaluated for pathology, cell proliferation, apoptosis, and vascularity. RESULTS: Curcumin causes a marked decrease in the extent of cell proliferation as measured by the BrdU incorporation assay and a significant increase in the extent of apoptosis as measured by an in situ cell death assay. Moreover, a significant decrease in the microvessel density as measured by the CD31 antigen staining was also seen. CONCLUSIONS: Curcumin could be a potentially therapeutic anti‐cancer agent, as it significantly inhibits prostate cancer growth, as exemplified by LNCaP in vivo, and has the potential to prevent the progression of this cancer to its hormone refractory state. Prostate 47:293–303, 2001. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998) · JAMA · doi:10.1001/jama.280.18.1569 · Cited by 6,658
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner, N., Carroll, P. R., Flax, J. D., Blumenfeld, W., & Folkman, J. (1993) · PubMed Central · Cited by 1,620
Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Huang, M., Smart, R. C., Wong, C.-Q., & Conney, A. H. (1988) · PubMed · Cited by 729
Why drinking green tea could prevent cancer
Jankun, J., Selman, S. H., Swiercz, R., & Skrzypczak-Jankun, E. (1997) · Nature · doi:10.1038/42381 · Cited by 718
Cited by
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Multiple biological activities of curcumin: A short review
Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.007 · Cited by 1,674
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
A Review of Curcumin and Its Derivatives as Anticancer Agents
Tomeh, M. A., Hadianamrei, R., & Zhao, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051033 · Cited by 949
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
Gupta, S. C., Patchva, S., Koh, W., & Aggarwal, B. B. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05648.x · Cited by 856
Biological Properties of Curcumin-Cellular and Molecular Mechanisms of Action
JOE, B., VIJAYKUMAR, M., & LOKESH, B. R. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490424702 · Cited by 816
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Ravindran, J., Prasad, S., & Aggarwal, B. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9128-x · Cited by 768
Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials
Strimpakos, A. S., & Sharma, R. A. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1769 · Cited by 645
Natural products for cancer prevention: a global perspective
Reddy, L., Odhav, B., & Bhoola, K. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00042-1 · Cited by 555
Role of chemopreventive agents in cancer therapy
Dorai, T., & Aggarwal, B. B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.013 · Cited by 529
Self-citationCurcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Bar-Sela, G., Epelbaum, R., & Schaffer, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790149738 · Cited by 479
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
Epstein, J., Sanderson, I. R., & MacDonald, T. T. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993667 · Cited by 464
Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo
Gou, M., Men, K., Shi, H., Xiang, M., Zhang, J., Song, J., Long, J., Wan, Y., Luo, F., Zhao, X., et al. (2011) · Nanoscale · doi:10.1039/c0nr00758g · Cited by 438
Role of Curcumin in Cancer Therapy
Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413
Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2
Syng-ai, C., Kumari, A. L., & Khar, A. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1101.3.9 · Cited by 395
López-Lázaro, M. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700238 · Cited by 389
Narayanan, N. K., Nargi, D., Randolph, C., & Narayanan, B. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24336 · Cited by 353
Biological and therapeutic activities, and anticancer properties of curcumin
PERRONE, D., ARDITO, F., GIANNATEMPO, G., DIOGUARDI, M., TROIANO, G., LO RUSSO, L., DE LILLO, A., LAINO, L., & LO MUZIO, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2749 · Cited by 348
Androgen deprivation therapy for prostate cancer: Current status and future prospects
Miyamoto, H., Messing, E. M., & Chang, C. (2004) · The Prostate · doi:10.1002/pros.20115 · Cited by 317
Curcumin exerts multiple suppressive effects on human breast carcinoma cells
Shao, Z., Shen, Z., Liu, C., Sartippour, M. R., Go, V. L., Heber, D., & Nguyen, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10183 · Cited by 313
Multiple molecular targets in cancer chemoprevention by curcumin
Thangapazham, R. L., Sharma, A., & Maheshwari, R. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080352 · Cited by 310
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3
Chendil, D., Ranga, R. S., Meigooni, D., Sathishkumar, S., & Ahmed, M. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207284 · Cited by 308
Iqbal, M., Sharma, S. D., Okazaki, Y., Fujisawa, M., & Okada, S. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.920106.x · Cited by 304
Role of Spices Beyond Food Flavoring: Nutraceuticals with Multiple Health Effects
Srinivasan, K. (2005) · Food Reviews International · doi:10.1081/fri-200051872 · Cited by 277
Nosrati, H., Sefidi, N., Sharafi, A., Danafar, H., & Kheiri Manjili, H. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.12.033 · Cited by 277
Molecular mechanisms of curcumin action: Gene expression
Shishodia, S. (2013) · BioFactors · doi:10.1002/biof.1041 · Cited by 263
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.021 · Cited by 260
Mahmood, K., Zia, K. M., Zuber, M., Salman, M., & Anjum, M. N. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.09.026 · Cited by 255
Pharmacokinetics and in vivo delivery of curcumin by copolymeric mPEG-PCL micelles
Kheiri Manjili, H., Ghasemi, P., Malvandi, H., Mousavi, M. S., Attari, E., & Danafar, H. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.10.003 · Cited by 108
Metadata
- Authors
- Dorai, T., Cao, Y., Dorai, B., Buttyan, R., & Katz, A. E.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2001-06
- Volume
- 47
- Issue
- 4
- Pages
- 293-303
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2139981029
- Cited by
- 338
- References
- 47
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.